Molecular genetics of plasma cell myeloma rs1045642 in P-glycoprotein : from genome to proteome in plasma cell myeloma
Multidrug resistance (MDR) is a phenomenon in malignancy whereby tumour cells generate mechanisms to resist cytotoxic treatments and previous research has demonstrated that a prominent cause of this resistance is via the expression and activity of certain protein within the surface of the cell. Howe...
Main Author: | Drain, Stephen |
---|---|
Published: |
University of Ulster
2010
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.551591 |
Similar Items
-
Effect of novel agents in myeloma
by: Srikanth, Muralikrishnan
Published: (2011) -
Drug resistance mechanisms in multiple myeloma
by: Scott, F. M.
Published: (1998) -
Identification of Breast Cancer Biomarkers by Mass-Spectrometry-Based Proteomics in Human Plasma and Breast Cancer Cell Lines
by: Hejazi, F.
Published: (2010) -
Malignant Paraproteinaemia : A Clinical and Pathological Review of Multiple Myeloma and Related Diseases
by: Mason, D. Y.
Published: (1976) -
Modulation of endoplasmic reticulum stress as a cancer therapeutic strategy using multiple myeloma as a model
by: Bagratuni, Tina
Published: (2010)